Select for export Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_267 PubMed 34734390 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P PubMed Published psilocybin AnxietyNeuroplasticityMechanism of Action Review Article More
Select for export Psychedelic medicines for mood disorders: current evidence and clinical considerations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/yco.0000000000000759 PubMed 34855694 Copy citation Copy BibTeX PubMed 2021-12-31 Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. Europe PMC Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_284 PubMed 34910289 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Rieser NM, Herdener M, Preller KH PubMed Published psilocybin AddictionNeuroplasticityMechanism of Action Other More
Select for export Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/24705470221115342 PubMed 35936944 Copy citation Copy BibTeX Unknown journal 2021-12-31 Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Systematic Review More
Select for export Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1076459 PubMed 36844032 Copy citation Copy BibTeX Frontiers in psychiatry 2021-12-31 Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM PubMed Published psilocybin DepressionBrain ImagingMechanism of Action Review Article More
Select for export Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.12.17.21267992 Copy citation Copy BibTeX medRxiv 2021-12-16 Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin Brain ImagingConsciousnessAging Other More
Select for export Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2021-12-15 National Council of Scientific and Technical Research, Argentina ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingMechanism of ActionMicrodosing Other More
Select for export Beating pain with psychedelics: Matter over mind? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2021.12.005 PubMed 34922987 Copy citation Copy BibTeX Unknown journal 2021-12-15 Elman I, Pustilnik A, Borsook D. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2021.11.30.470657 Copy citation Copy BibTeX bioRxiv 2021-12-06 Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMicrodosingCreativity Other More
Select for export P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.557 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Drummond E-Wen McCulloch, M. Madsen, Dea Siggaard Stenbæk, Søren Kristiansen, Brice Ozenne, P.S. Jensen OpenAlex Published psilocybin General Other More
Select for export P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2021.10.741 Copy citation Copy BibTeX European Neuropsychopharmacology 2021-11-30 Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt OpenAlex Published psilocybin DepressionReceptor Pharmacology Other More
Select for export Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5281/zenodo.5745892 Copy citation Copy BibTeX Zenodo (CERN European Organization for Nuclear Research) 2021-11-29 Enzo Tagliazucchi OpenAlex Published psilocybin Brain ImagingMicrodosingCreativity Other More
Select for export Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph14121213 PubMed 34959614 Copy citation Copy BibTeX Unknown journal 2021-11-23 Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J Europe PMC Published psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Review Article More
Select for export Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.2487 PubMed 34743319 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2021-11-21 Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Clinical Trial More
Select for export Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40263-021-00877-y PubMed 34791625 Copy citation Copy BibTeX Unknown journal 2021-11-16 Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Review Article More
Select for export [Rapid-acting antidepressants-neurobiological mechanisms of action]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00115-021-01225-7 PubMed 34766186 Copy citation Copy BibTeX Unknown journal 2021-11-10 Gass P, Vasilescu AN, Inta D. Europe PMC Published psilocybin DepressionNeuroplasticityMechanism of Action Animal Study More
Select for export Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01706-y PubMed 34750350 Copy citation Copy BibTeX Translational Psychiatry 2021-11-07 Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.15509 PubMed 34519052 Copy citation Copy BibTeX Unknown journal 2021-10-21 Kozlowska U, Nichols C, Wiatr K, Figiel M. Europe PMC Published psilocybin DepressionAddictionNeuroplasticity Clinical Trial More
Select for export Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.735523 PubMed 34744825 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-10-19 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC Europe PMC Published psilocybin Eating DisordersEnd-of-Life DistressNeuroplasticity Clinical Trial More
Select for export Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01603-4 PubMed 34601495 Copy citation Copy BibTeX Translational Psychiatry 2021-10-01 Vejmola Č, Tylš F, Piorecká V, Koudelka V, Kadeřábek L, Novák T Europe PMC Published psilocybinpsilocin Brain Imaging Other More
